Initiation of DNA replication requires the function of MCM gene products, which participate in ensuring that DNA replication occurs only once in the cell cycle. Expression of all mammalian genes of the MCM family is induced by growth stimulation, unlike yeast, and the mRNA levels peak at G1/S boundary. In this study, we examined the transcriptional activities of isolated human MCM gene promoters. Human MCM5 and MCM6 promoters with mutation in the E2F sites failed in promoter regulation following serum stimulation and exogenous E2F expression. In addition, we identi®ed a novel E2F-like sequence in human MCM6 promoter which cooperates with the authentic E2F sites in E2F-dependent regulation. Forced expression of E2F1 could induce expression of all members of the endogenous MCM genes in rat embryonal ®broblast REF52 cells. Our results demonstrated that the growth-regulated expression of mammalian MCM5 and MCM6 genes, and presumably other MCM members, is primarily regulated by E2F through binding to multiple E2F sites in the promoters.
Introduction
In the cell cycle of eukaryotic cells, replication of DNA occurs once per cell cycle to ensure the integrity of the genome. The mechanism that inhibits re-replication of the DNA that had already replicated in the current S phase seems to be conserved from yeast to human. A model in Xenopus hypothesized a trans-acting factor (licensing factor), which distinguishes replicated DNA from unreplicated one (Blow and Laskey, 1988) . On the other hand, the MCM family genes have been identi®ed in Saccharomyces cerevisiae as essential genes involved in the initiation of DNA replication. MCM gene products are reminiscent of a putative licensing factor. A series of experiments with Xenopus egg extract identi®ed Mcm molecules as components of a putative licensing factor (Chong et al., 1995; Kubota et al., 1995 Madine et al., 1995; Thommes et al., 1997) . At present, there are six genes of the MCM family (MCM2-7) that have been identi®ed in yeast, Xenopus, and human. Mcm proteins seem to regulate the initiation at the replication origin where the loading of the proteins onto the origin recognition complex (ORC) is regulated by Cdc6 and cyclin-dependent kinases (Donovan et al., 1997; Tanaka et al., 1997) . However, the mechanism(s) by which Mcm proteins control the initiation of DNA replication remains unclear.
Xenopus Mcm proteins seem to be able to access replicated DNA only after the breakdown of nuclear envelope in M phase. The Mcm proteins in S. cerevisiae are in the nucleus during G1 phase but disappear from the nucleus upon the initiation of S phase, whereas Mcm proteins in ®ssion yeast and mammalian cells are in the nucleus throughout the mitotic cell cycle. Unlike yeast, in which expression of the Mcm proteins and messages is stable during the cell cycle, mammalian cells show a dramatic induction of MCM mRNAs at G1/S boundary coupled with a signi®cant rise in protein levels upon growth stimulation such as stimulation of resting ®broblasts with serum (Tsuruga et al., 1997a) . Thus, in mammalian cells, the transcriptional mechanism of expression of the MCM genes is, at least in part, central to the regulation of Mcm activities. To address this issue, we previously isolated the 5'¯anking regions of human MCM5 (HsMCM5) and MCM6 (HsMCM6) genes (Tsuruga et al., 1997a,b) . Both sequences were found to have putative E2F binding consensus sites, suggesting E2F-dependent regulation of the HsMCM5 and HsMCM6 genes.
Overexpression of E2F has been shown to induce cellular DNA synthesis in serum starved ®broblasts (DeGregori et al., 1997; Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994) , suggesting that genes critically involved in regulation of DNA replication are targets of E2F. Indeed, E2F is known to regulate a class of genes involved in DNA replication (La Thangue, 1994; Nevins, 1992) . These include genes for enzymatic machinery for DNA synthesis, such as dihydrofolate reductase (DHFR) and DNA polymerase a, and regulatory molecules for the initiation of DNA replication, such as HsOrc1 and HsCdc6 (Ohtani et al., 1996 (Ohtani et al., , 1998 Yan et al., 1998) . HsOrc1 and HsCdc6 may be necessary for the initiation of DNA replication. However, overexpression of HsOrc1 or HsCdc6 is not sucient for the induction of DNA synthesis as shown in rat embryonal ®broblast REF52 cells (Ohtani et al., 1998) , implying other E2F targets than Orc1 and Cdc6 in inducing DNA synthesis in REF52 cells.
In the present study, we show that the cell growthregulated promoter activity of HsMCM5 and HsMCM6 is primarily regulated by E2F through binding to the multiple E2F recognition sites of HsMCM5 and HsMCM6 promoters. Furthermore, expression of E2F1 induces all genes of the endogenous MCM family in REF52 cells. Our results indicate that the MCM family genes are critical E2F target genes in the regulation of DNA replication.
Results

Cell proliferation-regulated expression of MCM family genes in REF52 cells
We have recently reported that serum stimulation induced expression of all genes of the MCM family in human lip ®broblast KD cells and normal rat kidney ®broblast NRK cells (Tsuruga et al., 1997a,b) . Serumdependent expression of the MCM family genes was further examined in rat embryonal ®broblast REF52 cells, which were used for a series of transfection experiments. REF52 cells were made quiescent by culture in 0.1% fetal bovine serum (FBS) for 48 h then stimulated to re-enter the cell cycle by the addition of serum. The level of mRNA expression of each MCM gene post-serum stimulation was monitored by Northern blotting with poly(A) + RNA. The latter was puri®ed from cells harvested at quiescence and at various time intervals after the addition of serum. Serum-starved quiescent REF52 cells produced lower levels of mRNAs for all MCM genes compared with asynchronously growing cells (Figure 1 ). Serum stimulation induced a transient marked inhibition of expression of MCM mRNAs at 4 h, which was followed with a profound increase for up to 12 h. The reduction at 4 h after stimulation may be due to the paucity of general transcription factors which are required for many genes activated at this stage. The levels of MCM mRNAs remained persistently high at least until 28 h post-stimulation. At 16 h post-serum stimulation REF52 cells commenced DNA synthesis which was determined by [ 3 H]thymidine uptake (data not shown). These results indicate that MCM mRNA expression parallels proceeding to G1/S boundary of the cell cycle progression upon the addition of serum, implying the involvement of cell growth regulation in the expression of mammalian MCM genes.
HsMCM5 and HsMCM6 promoters
Our previous results showed multiple putative E2F sites in 5'¯anking sequences of the HsMCM5 and HsMCM6 genes (Tsuruga et al., 1997a,b) . We wished to determine the functional signi®cance of these sequences in the regulation of HsMCM5 and HsMCM6 genes. Transcriptional start sites were mapped by RNase protection assays. By using RNA probes spanning sequences upstream of HsMCM5 and HsMCM6 cDNAs, fragments with multiple sizes were protected with mRNAs from human T cell lines MT-2 and Kit 225 (Figure 2A ), indicating multiple transcriptional start sites around which no typical splicing acceptor consensus sequences were found. These possible transcriptional start sites of the HsMCM5 gene clustered about 15 bp upstream of the 5' end of HsMCM5 cDNA (Tsuruga et al., 1997a) . There are two sets of putative E2F binding elements arranged in an overlapping fashion in the 5'¯anking sequence of HsMCM5 cDNA. One set (E2F sites III+IV) is located about 190 bp upstream of the 5' end of cDNA while the other (E2F sites I+II) 2 bp downstream of the 5' end of cDNA ( Figure 2B) ; i.e., each one set lies downstream and upstream of the transcriptional initiation sites. Similarly, RNase protection assay of the HsMCM6 5'¯anking sequence indicated multiple transcriptional start sites in 20 to 1 bp upstream of the 5' end of cDNA (Tsuruga et al., 1997b) . Our independent search found, in addition to two sets of overlapping E2F sites (E2F sites I ± IV) recognized previously (Tsuruga et al., 1997b) , another putative E2F site (E2F like site V), which overlapped with the clustered transcriptional start sites. The 5'¯anking sequences of the HsMCM5 and HsMCM6 genes contained multiple Sp1 sites but not typical TATA box. These characteristics are similar to those of previously reported genes, such as B-myb, E2F1 and HsOrc1, which are primarily regulated by E2F (Johnson et al., 1994; Lam and Watson, 1993; Ohtani et al., 1996) . Figure 1 Growth-regulated expression of MCM family genes in REF52 cells. REF52 cells were serum-starved and re-stimulated with 20% FBS. Cells were harvested at indicated time intervals after the addition of serum. Poly(A) + RNA prepared from 660 mg of total RNA was subjected to electrophoresis on a 1% agarose gel and transferred to a nylon membrane. The blot was sequentially probed with HsMCM2 through HsMCM7 and GAPDH cDNAs. Lane A indicates mRNA expression in asynchronously cultured REF52 cells To determine whether the 5'¯anking regions of the HsMCM5 and HsMCM6 genes were indeed responsible for the growth-dependent regulation of expression of HsMCM5 and HsMCM6 genes, we fused these sequences to a luciferase reporter gene and assayed the promoter activities in serum-starved and serumstimulated REF52 cells. REF52 cells were transfected with HsMCM5-and HsMCM6-luciferase (Luc) reporter plasmids and a plasmid containing the bgalactosidase gene as an internal control, and then made quiescent by serum starvation. Serum was added to stimulate transfected REF52 cells to re-enter into the cell cycle. Cell extracts were prepared at indicated time intervals and assayed for luciferase activity, which was corrected by b-galactosidase activity. As shown in Figure 2C the promoter activities of both genes were low in quiescent and early G1 cells but markedly increased as the cell cycle progressed through G1 to S phase in response to serum stimulation. The increase in promoter activities paralleled accumulation of MCM5 and MCM6 mRNAs in Northern blotting (Figures 1 and 2C). We therefore conclude that the 5'¯anking regions of the HsMCM5 and HsMCM6 genes contain promoter sequences responsible for the growthregulated expression of those genes.
Activation of HsMCM5 and HsMCM6 promoters by E2F
Given the presence of multiple putative E2F recognition sequences within the HsMCM5 and HsMCM6 promoters, we then examined whether the putative E2F recognition sequences are functional elements in the regulation of promoter activities.
The ability of these putative E2F sites to bind E2F was examined by the gel mobility shift assay. Typical E2F sites from the DHFR gene showed a speci®c binding with total cell extract from F9 cells which are shown to contain a large amount of free E2F molecules (La Thangue et al., 1990) . This complex formation was completely inhibited by any wild type oligonucleotide of the putative E2F sites in HsMCM5 and HsMCM6 promoters, with the exception of the HsMCM6 E2F like site V which was less eective in inhibiting the complex formation ( Figure 3A ). Their mutant forms with two-base substitution did not show appreciable eects on complex formation. Furthermore, all of the putative E2F recognition sequences of HsMCM5 and HsMCM6, with the exception of HsMCM6 E2F like site V, were able to form complexes with the F9 cell extract. The complex formation was competed away with either a typical E2F site or own oligonucleotides, whereas mutant forms of the typical E2F site and MCM gene E2F sites failed to inhibit complex formation ( Figure 3B ). The combination of HsMCM6 E2F like site V and the F9 cell extract generated a complex whose formation was not interfered by typical E2F site oligonucleotides. These results indicate that the putative E2F recognition sequences (sites I ± IV) in the HsMCM5 and HsMCM6 promoters are authentic E2F binding sites. On the other hand, E2F like site V of HsMCM6 preferentially binds to a factor(s) dierent from E2F.
These ®ndings prompted us to examine whether HsMCM5 and HsMCM6 promoters could respond to E2F in the transient transfection assay. The HsMCM5 and HsMCM6 promoter-driven luciferase reporter plasmids were transfected into REF52 cells together with a plasmid expressing E2F1, E2F2 or E2F3. Following transfection, the cells were grown in a medium containing 0.1% FBS for 36 h. Cell extracts were prepared and assayed for luciferase activity. The activity of HsMCM5 promoter increased seven-and sixfolds by exogenous expression of E2F1 and E2F2, respectively, and to a lesser extent (threefolds) by E2F3 ( Figure 4A ). Introduction of mutation in two sets of the overlapping E2F sites abolished E2F1-dependent activation ( Figure 4C ), indicating a direct involvement of E2F in the activity of HsMCM5 promoter. The mutant exhibited high levels of promoter activity, compared with the wild type with E2F1, even without E2F1 and little, if any, activation by E2F1. These results show that the HsMCM5 promoter is activated by E2F through multiple E2F sites.
Similarly, exogenous expression of E2F1, E2F2 and E2F3 in quiescent REF52 cells induced eight-to threefold activation of the HsMCM6 promoter ( Figure 4B ). Mutation was introduced into two sets of the putative overlapping E2F sites (Mut I ± IV). The basal activity of the mutant promoter without E2F increased threefolds relative to that of the wild type, and the activity with E2F1 was similar to that of the wild type ( Figure 4D ), resulting in a decrease in fold activation from 8 to 2. These results clearly indicate that the putative overlapping E2F sites are, at least in part, responsible for activation by E2F, and suggest the presence of another E2F responsive element(s) in the HsMCM6 promoter because the mutant still retains responsiveness to E2F1. The newly identi®ed E2F like sequence (E2F like site V: 714 to 721), which is diverged from typical E2F site in terms of nucleotide sequence and non-preferential binding of E2F, was a likely candidate. To examine this notion, we mutated this site and examined the response to E2F1. Introduction of mutation in E2F like site V in addition to the two overlapping typical E2F sites (Mut I ± V) completely abolished the ability of the promoter to respond to E2F1, implying involvement of E2F like site V in E2F-dependent response ( Figure  4D ). E2F like site V single mutant (Mut V), however, showed reduced promoter activity either with or without E2F1, resulting in activation by E2F1 which was essentially similar to the wild type.
Critical involvement of E2F in cell cycle-dependent regulation of HsMCM5 and HsMCM6 promoter activities
In view of the growth-dependent control of the HsMCM5 and HsMCM6 gene expression (Figure 1) , we further investigated the role of E2F sites in growthdependent regulation of HsMCM5 and HsMCM6 promoters. For this purpose, we compared the kinetics of the activity of E2F mutant promoter with that of the wild type in REF52 after inducing cell cycle progression by stimulation with serum (20% FBS) of quiescent cells cultured in 0.1% FBS for 48 h.
The mutant of E2F sites (Mut I ± IV) in the HsMCM5 promoter failed to control expression in response to stimulation of cell growth. The activity of the mutant promoter in quiescent cells was profoundly higher than that of the fully stimulated wild type E2F-mediated expression of mammalian MCM genes K Ohtani et al promoter and remained persistently high after growth stimulation. This result indicates that growth-regulated promoter activity of HsMCM5 is absolutely dependent on E2F. The reason of the extremely high mutant activity in serum-starved conditions is not known at present.
Introduction of mutation in two sets of the overlapping E2F sites (Mut I ± IV) in HsMCM6 E2F-mediated expression of mammalian MCM genes K Ohtani et al promoter increased the basal activity in serum-starved conditions. Addition of serum stimulated the mutant promoter in a manner similar to the wild type promoter, although less activation was associated with the mutant. However, the addition of mutation in E2F like site V to the I ± IV mutant completely abolished responsiveness to serum stimulation with the promoter activity as low as that of the wild type under serum starvation conditions, in contrast to the elevated basal activity of the E2F site I ± IV mutant. The E2F like site V mutation (Mut V) reduced the activity of the promoter in serum-starved and serum-stimulated conditions with the same fold activation as the wild type. It is possible that the low activity of this mutant was due to the destruction by mutation of E2F like site V of the native transcriptional start sites while sparing cryptic transcriptional start sites, thus resulting in a loss of regulation by E2F. In any event, E2F seems to be the main regulator of growth-dependent activation of the HsMCM6 promoter.
Activation of expression of all endogenous MCM genes by E2F1
In order to examine the role of E2F in the regulation of expression of MCM family genes in a more physiological state, we examined the expression of endogenous MCM genes in response to E2F1. E2F1 recombinant adenovirus (Ad-E2F1) was used to Gel mobility shift assays were performed as described for (A). End-labeled double stranded oligonucleotides containing putative E2F recognition sites I+II or III+IV from the HsMCM5 promoter or putative E2F recognition sites I+II, III+IV or E2F like site V from the HsMCM6 promoter were used as probes. Competition assays were performed by adding 100-molar excess of the same unlabeled oligonucleotides to the gel shift reaction mixtures express E2F1 in serum-starved quiescent REF52 cells. Cells were harvested for preparation of RNA, which was subjected to Northern blot analysis to monitor levels of MCM5 and MCM6 mRNAs. The levels of mRNAs of both genes were markedly increased upon infection with Ad-E2F1 virus compared to those with control virus infection ( Figure 6 ). In addition, exogenous expression of E2F1 signi®cantly increased the levels of mRNAs for MCM2, MCM3, MCM4 and MCM7. Although no information on rat MCM5 and MCM6 promoters is available, considering that the HsMCM5 and HsMCM6 promoters have E2F sites that primarily regulate promoter activities in response to growth stimulation, it is highly likely that endogenous MCM5 and MCM6 genes were induced through a direct action of E2F1 in REF52 cells.
Moreover, the fact that the 5'¯anking sequences of murine MCM3 (Kimura et al., 1994) and human MCM7 genes contain putative E2F sites suggests that expression of MCM3 and MCM7 is also a result of direct eect of E2F1.
Discussion
The present study provides evidence that the growthregulated expression of mammalian MCM5 and MCM6 genes is mediated by E2F. Accumulating evidence suggests that the expression of mammalian genes regulatory to DNA replication is growth-dependent, mainly through the action of the transcription factor E2F (Ohtani et al., 1996 (Ohtani et al., , 1998 Yan et al., 1998) . The 1384-bp and 754-bp fragments upstream of HsMCM5 and HsMCM6 genes, respectively, mimic the kinetics of promoter activities of the rat endogenous MCM5 and MCM6 genes in response to serum stimulation (Figure 2c vs Figure 1) . These results indicate not only that the 1348-bp and 745-bp sequences encompass the transcriptional regulatory region of the genes, but also that humans and rats have a similar mechanism for the regulation of expression of MCM5 and MCM6 genes. As is the case with genes whose expression is primarily regulated by E2F (Johnson et al., 1994; Lam and Watson, 1993; Ohtani et al., 1996) , the E2F sites of the HsMCM5 and HsMCM6 genes are located near the RNA start sites in a multiple copy form in transcriptional regulatory regions. We previously found two sets of overlapping E2F consensus sequences in the 5'¯anking regions of the HsMCM5 and HsMCM6 genes (Tsuruga et al., 1997a,b) . One of the two sets of HsMCM5 lies Figure 6 Induction of all members of endogenous MCM family genes by E2F1. REF52 cells were brought into quiescence by serum starvation for 48 h and infected with either Ad-E2F1 or Ad-Con. Infected cells were harvested at 21 h post-infection, and poly(A) + RNA was prepared and then separated by agarose gel electrophoresis. The RNAs were transferred to a nylon membrane and probed sequentially with either HsMCM2 through HsMCM7 or GAPDH cDNA upstream of the clustered transcriptional start sites determined by RNA protection assay and the other downstream of those. The latter is thus in the 5' untranslated region of the HsMCM5 mRNA. Two sets of MCM6 are upstream of the clustered transcriptional start sites. We demonstrated in this study that these E2F sites can potentially bind to E2F and to regulate the expression of genes. We also identi®ed an additional E2F-like site in the HsMCM6 gene, which overlaps the transcriptional start sites.
Growth stimulation-dependent regulation of expression of HsMCM5 was abolished by disruption of both sets of the overlapping E2F sites in the promoter, clearly demonstrating the critical function of E2F in expression of the HsMCM5 gene. The E2F site mutant showed higher activity than the wild type in serumstarved conditions and the activity remained unchanged after serum stimulation. Many of E2F responsive genes such as B-myb, E2F1 and HsOrc1, are actively suppressed in serum-starved conditions. Mutation of the E2F sites in these genes relieves the suppression, resulting in a higher basal activity in serum-starved conditions (Johnson et al., 1994; Lam and Watson, 1993; Ohtani et al., 1996) . The function of E2F sites in the HsMCM5 promoter seems similar to that of the E2F responsive genes. E2F complex with a member of the Rb family on the E2F sites is thought to be suppressive in transcription from promoters in serum-starved conditions (Smith et al., 1996) . Our knowledge at present is inadequate to account for the extremely high activity of the HsMCM5 promoter in serum-starved conditions relative to that of the wild type promoter fully stimulated with serum. One possibility is that mutation of the 3' set of the overlapping E2F sites, which are present in the 5' untranslated region of HsMCM5, increases the stability of the mRNA. Alternatively, the mutation in the 5' untranslated region might facilitate the eciency of translation from mRNA molecules.
The mutant of two sets of the overlapping E2F sites (Mut I-IV) of HsMCM6 is dierent from that of HsMCM5; the basal activity in serum-starved conditions is higher than that of the wild type but signi®cantly lower than that of the wild type stimulated by growth signals. Moreover, the MCM6 mutant could still be activated by E2F1 and serum similar to the wild type, indicating that E2F sites I ± IV are partly responsible for the cell cycle-regulated expression and are presumably suppressed by binding of E2F complex with Rb family proteins in serumstarved conditions. This conclusion implies another E2F responsive element(s). In this context, it is intriguing to imagine that newly identi®ed E2F like site V plays a pivotal role in the regulation of expression in response to E2F. Indeed, mutation of E2F like site V with mutation of E2F site I ± IV completely abolished E2F-dependent regulation. Obviously E2F like site V is involved in E2F-dependent regulation of HsMCM6 expression. Nevertheless this E2F like site V element seems to be dierent from the typical E2F sites identi®ed so far in various genes in that the E2F like site V mutant did not show elevation of the basal promoter activity in serum-starved conditions and the E2F site oligonucleotide was an ineective competitor for the complex formation of a typical E2F site. The reason that the E2F site I ± V mutant did not show higher activity than that of the wild type is not known at present. One possibility is that the mutation of E2F like site V destroyed some of the transcriptional start sites. We assume, however, that this is less likely because the E2F like site V single mutant showed essentially the similar response to stimulations as the wild type promoter. Thus, although both E2F sites I ± IV and E2F like site V are responsible for regulation of HsMCM6 expression, which is activated by serum stimulation or overexpression of E2F1, they may mediate such regulation independently. Collectively, expression of HsMCM6 is assured by combinatorial action of multiple E2F sites. In any event, the E2F sites in HsMCM5 and HsMCM6 promoters are major elements regulatory to growth stimulation. This notion is supported by the induction of endogenous MCM5 and MCM6 genes by overexpression of E2F1 in REF52 cells.
Overexpression of E2F1 induced all endogenous genes of the MCM family in REF52 cells. Considering the direct action of E2F on HsMCM5 and HsMCM6 promoters and putative E2F binding consensus sites in murine MCM3 and human MCM7 5'¯anking sequences (Kimura et al., 1994; Kiyono et al., 1996) , it is possible that the induction of those genes in REF52 cells is directly mediated by E2F. Although we do not have any information on 5'¯anking sequences of MCM2 and MCM4, the induction of both genes might be a direct eect of E2F.
The Mcm proteins are rather abundant proteins even in serum-starved resting ®broblasts (Tsuruga et al., 1997a) . Thus, expression of the MCM genes may not be rate limiting for serum-starved ®broblasts to initiate DNA replication after stimulation with serum. However, in certain cellular circumstances such as prolonged serum starvation and treatment with anti-sense oligonucleotides speci®c to HsMCM7, the Mcm family proteins seem to decrease their levels sucient enough for rate limiting . This may be similar to the in vivo situation in which most cells in vivo are in a resting state while only a very small proportion of the cells, e.g., in cases of immune responses and injury, reenters the cell cycle after a prolonged period of resting state. Under such conditions, transcriptional activation of the MCM family genes is important in the regulation of DNA replication.
Overexpression of E2F has been shown to induce cellular DNA synthesis in serum-starved ®broblasts (DeGregori et al., 1997; Johnson et al., 1993; Qin et al., 1994; Shan and Lee, 1994) , suggesting that genes critically involved in the regulation of DNA replication are targets of E2F. It is possible that other E2F target genes may exist and mammalian homologs of CDC7, DBF4 and CDC45 are potential candidates (Sato et al., 1997) . Identi®cation of other E2F target genes should provide insight into the mechanisms that regulate the initiation of DNA replication in mammalian cells.
Materials and methods
Cell culture
Human T-cell lines MT-2 and Kit 225 were maintained in RPMI 1640 containing 10% FBS supplemented with 0.5 nM IL-2 (kindly provided by Ajinomoto, Yokohama, E2F-mediated expression of mammalian MCM genes K Ohtani et al Japan) for Kit 225. A rat embryonic ®broblast cell line REF52 and murine teratocarcinoma cell line F9 were maintained in Dulbecco modi®ed Eagle medium (DMEM) containing 10% FBS. For experiments of promoter activity assay and expression of endogenous MCM mRNAs, REF52 cells were serum-starved in DMEM containing 0.1% FBS for 48 h and stimulated by addition of 20% FBS for indicated time intervals.
Northern (RNA) blot assay
Total RNA extraction was carried out using Isogen (Nippon Gene) and poly(A) + RNA was puri®ed from total RNA by PolyA Tract (Promega) according to the protocol recommended by the manufacturer. Gel electrophoresis, transfer to nylon membrane, and hybridization were performed as described previously (Johnson et al., 1994) . The probes for MCM2 through MCM7 were the AscI/NotI fragments cut out from pGEX8T-HsMCM2, 3, 5 and 7, and pBAC3-HsMCM4 and 6. The GAPDH cDNA was used as a control probe. Radioactivity of the signals was measured with an image analyzer BAS 1500 (Fuji Film).
RNase protection assay
RNase protection assay was performed as described previously (Johnson et al., 1994) . Brie¯y, 524-base and 622-base anti-sense RNA probes beginning at +43 and +35 (relative to 5' ends of the cDNA as +1) in the HsMCM5 and HsMCM6 5' untranslated regions, respectively, were hybridized to 1 mg of yeast tRNA, MT-2 or Kit 225 poly(A) + RNA for 16 h at 658C. RNA hybrids were digested by RNase A (1 unit/ml) and RNase T1 (50 units/ ml) at 378C for 30 min, and protected fragments were analysed on a 7% polyacrylamide sequencing gel. Sequencing reactions using primers corresponding to the end of the RNase protection probes were used as markers.
Construction of plasmids
HsMCM5 (71384 to +43) and HsMCM6 (7754 to +35) 5'¯anking sequences obtained by PCR using Promoter Finder DNA walking kit (Clontech Laboratories) were subcloned into the NcoI ± SacI sites of pPBV2 (Wako) to construct pHsMCM5-Luc(71384) and pHsMCM6-Luc(7754), respectively. The mutant of two sets of the overlapping E2F sites in the pHsMCM5-Luc(71384) construct was made by site-directed mutagenesis which changed TTTCCCGCGAAA (nt +2 to +13) to TTTCCATCGAAA and TTTCGCGCCAAA (nt 7194 to 7183) to TTTCGATCCAAA, generating pHsMCM5-Luc(E2F7). The mutants of putative E2F sites in the pHsMCM6-Luc(7754) construct were similarly prepared by changing TTTGGCGCGAAA (nt 7107 to 796) to TTTGGATCGAAA and TTTGGCGCGAAA (nt 7169 to 7158) to TTTGGATCGAAA, and GCGCGCAA (nt 721 to 714) to GCGATCAA, generating pHsMCM6-Luc(E2FI-IV7) and pHsMCM6-Luc(E2FV7), respectively. pHsMCM6-Luc(E2FI-V7) has both mutations. The E2F1, E2F2, and E2F3 expression plasmids, as well as the pCMV-b-gal, have been described previously (Johnson et al., 1994) .
Transfection assay
Transfection of REF52 cells and luciferase assay were performed as described previously (Johnson et al., 1993) . REF52 cells were transfected with expression and reporter plasmids by the calcium-phosphate method together with b-galactosidase expression vector, pCMV-b-gal, which was used as an internal control to monitor the transfection eciency. Luciferase activities were assayed using Luciferase Assay System (Promega) and normalized to bgalactosidase activities, which were determined by the method of Rose and Botstein (1983) . All assays were performed at least three times in duplicates and representative data are presented.
Gel mobility shift assay Double-stranded oligonucleotides containing each of the putative E2F recognition sites in the 5'¯anking regions of HsMCM5 (nt 7194 to 7183 and +2 to +13) and HsMCM6 (7169 to 7158, 7107 to 796 and 721 to 714) and mutants of these sequences were used for the assay. Sequences were: HsMCM5 wild type-I+II: 5'-TTGTTTTTCCCGCGAAACTCGG-3'; HsMCM5 mutant-I+II: 5'-TTGTTTTTCCATCGAAACTCGG-3'; Hs-MCM5 wild type-III+IV: 5'-AGAAGTTTCGCGC-CAAATTGTT-3'; HsMCM5 mutant-III+IV: 5'-AGAAG-TTTCGATCCAAATTGTT-3'; HsMCM6 wild type-I+II: 5'-TCAGGTTTGGCGCGAAATCTCC-3'; HsMCM6 mutant-I+II: 5'-TCAGGTTTGGATCGAAATCTCC-3'; Hs-MCM6 wild type-III+IV: 5'-TTGCATTTGGCGC-GAAATCCCT-3'; HsMCM6 mutant-III+IV: 5'-TTGCA-TTTGGATCGAAATCCCT-3'; HsMCM6 wild type-V: 5'-CGGCGGCGCGCGCAAAGCTGCA-3'; HsMCM6 mutant-V: 5'-CGGCGGCGCGATCAAAGCTGCA-3'.
These double-stranded oligonucleotides were also used as competitors at 100-fold molar excess. A typical E2F site from the DHFR promoter (Ikeda et al., 1996) was also used as a probe. Gel mobility shift assay was performed as described previously (Yee et al., 1989) . In brief, radiolabeled probes were incubated with F9 cell extract in the presence or absence of unlabeled competitor oligonucleotides for 20 min at room temperature, followed by electrophoresis in a 5% polyacrylamide gel in TBE (50 mM Tris-borate/1 mM EGTA) containing 5% glycerol.
Infection with recombinant adenoviruses
The recombinant adenovirus for expression of E2F1, Ad-E2F1 and control virus, Ad-Con (previously Ad-CMV), have been described previously (Schwarz et al., 1995) . Quiescent REF52 cells cultured in DMEM containing 0.1% FBS for 48 h were infected with Ad-E2F1 or AdCon at multiples of 300 plaque forming units per cell in 2 ml per 150 mm plate for 1 h at 378C (Schwarz et al., 1995) . Cells were further cultured in DMEM containing 0.1% FBS for 21 h and harvested for RNA isolation.
